Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
EDAP TMS
EDAP
EDAP TMS
Rising Health Spending And Aging Populations Will Boost HIFU Utilization
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
13 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$14.00
90.3% undervalued
intrinsic discount
16 Aug
US$1.36
Loading
1Y
-67.6%
7D
7.9%
Author's Valuation
US$14.0
90.3% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$14.0
90.3% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-22m
92m
2014
2017
2020
2023
2025
2026
2028
Revenue €91.8m
Earnings €11.5m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
15.20%
Medical Equipment revenue growth rate
0.45%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.61%
Calculation
€11.47m
Earnings '28
x
49.46x
PE Ratio '28
=
€567.26m
Market Cap '28
€567.26m
Market Cap '28
/
37.96m
No. shares '28
=
€14.94
Share Price '28
€14.94
Share Price '28
Discounted to 2025 @ 8.62% p.a.
=
€11.66
Fair Value '25
€11.66
Fair Value '25
Converted to USD @ 1.1701 EUR/USD Exchange Rate
=
US$13.64
Fair Value '25